Appointment & Re-appointment of Directors
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd's board, at its meeting on 29th July 2025, approved the appointment of Mr. Sumukh Prabhakar Vartak as an additional Whole Time Director for 5 years starting 29th July 2025, subject to shareholder approval. He holds an MBA and has over 21 years of experience in the Active Pharmaceutical Ingredients (API) sector, covering marketing strategy and business development across regulated and semi-regulated markets. The board also approved the re-appointment of Ms. Kajal Kothari as Independent Director for a second 5-year term from 09th September 2025 to 08th September 2030; she is a pharmacy graduate and co-founder of a digital marketing agency. Additionally, Mr. Rajkumar Baheti was re-appointed as Independent Director for a second 5-year term from 10th February 2026 to 09th February 2031, bringing 20+ years of shipping and logistics experience.
This is a routine board restructuring update — one new executive director joins to strengthen the API/pharma business, while two independent directors continue for another term, supporting continuity of governance. Shareholders will need to approve these appointments at the upcoming AGM, but the changes are unlikely to have a direct material impact on the stock price.